AI Insight
Researchers have discovered a connection between the gut and heart that may explain why sleep apnea increases cardiovascular disease risk. Studies in mice showed that disabling a bile acid receptor called FXR significantly reduced arterial plaque accumulation. This finding suggests that gut microbes and their chemical signals could be targeted for new treatments to prevent heart disease in sleep apnea patients.
Why it matters
This discovery could lead to novel therapeutic approaches for reducing cardiovascular complications in people with sleep apnea by targeting gut-based mechanisms rather than only treating the breathing disorder itself. The research opens possibilities for microbiome-based interventions or drugs that modulate bile acid signaling to prevent heart disease.
A surprising gut-heart connection may help explain why sleep apnea increases the risk of cardiovascular disease. In mice, disabling a bile acid receptor called FXR sharply reduced plaque buildup, opening the door to potential new treatments based on gut microbes and their chemical signals.
Source: Sleep apnea’s hidden heart disease trigger found in the gut